{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:44:13Z","timestamp":1766155453900,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1038\/s41574-021-00493-2","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T09:03:26Z","timestamp":1618391006000},"page":"321-322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Relugolix \u2014 new treatment for uterine fibroid-related heavy bleeding"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5544-2653","authenticated-orcid":false,"given":"Donna D.","family":"Baird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quaker E.","family":"Harmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart, E. A. et al. Uterine fibroids. Nat. Rev. Dis. Primers 2, 16043 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"493_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/AOG.0b013e318183fbab","volume":"112","author":"ACOG practice bulletin","year":"2008","unstructured":"ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas. Obstet. Gynecol. 112, 387\u2013400 (2008).","journal-title":"Obstet. Gynecol."},{"key":"493_CR3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJMoa2008283","volume":"384","author":"A Al-Hendy","year":"2021","unstructured":"Al-Hendy, A. et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N. Engl. J. Med. 384, 630\u2013642 (2021).","journal-title":"N. Engl. J. Med."},{"key":"493_CR4","doi-asserted-by":"publisher","first-page":"2414609","DOI":"10.1155\/2018\/2414609","volume":"2018","author":"TD Lewis","year":"2018","unstructured":"Lewis, T. D., Malik, M., Britten, J., San Pablo, A. M. & Catherino, W. H. A Comprehensive Review of the Pharmacologic Management of Uterine Leiomyoma. Biomed. Res. Int. 2018, 2414609 (2018).","journal-title":"Biomed. Res. Int."},{"key":"493_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/TCRM.S147318","volume":"15","author":"M Farris","year":"2019","unstructured":"Farris, M., Bastianelli, C., Rosato, E., Brosens, I. & Benagiano, G. Uterine fibroids: an update on current and emerging medical treatment options. Ther. Clin. Risk Manag. 15, 157\u2013178 (2019).","journal-title":"Ther. Clin. Risk Manag."},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jhep.2020.11.041","volume":"74","author":"B Mozzanega","year":"2021","unstructured":"Mozzanega, B. Ulipristal acetate and liver-injuries: while Esmya is revoked, EllaOne is allowed in repeated self-administrations possibly exceeding UPA toxic-dosing with Esmya. J. Hepatol. 74, 750\u2013751 (2021).","journal-title":"J. Hepatol."},{"doi-asserted-by":"crossref","unstructured":"Ciebiera, M. et al. The evolving role of natural compounds in the medical treatment of uterine fibroids. J. Clin. Med. 9 (2020).","key":"493_CR7","DOI":"10.3390\/jcm9051479"},{"key":"493_CR8","first-page":"2936","volume":"30","author":"DD Baird","year":"2015","unstructured":"Baird, D. D., Saldana, T. M., Shore, D. L., Hill, M. C. & Schectman, J. M. A single baseline ultrasound assessment of fibroid presence and size is strongly predictive of future uterine procedure: 8-year follow-up of randomly sampled premenopausal women aged 35-49 years. Hum. Reprod. 30, 2936\u20132944 (2015).","journal-title":"Hum. Reprod."},{"key":"493_CR9","first-page":"528376","volume":"2013","author":"GP Flake","year":"2013","unstructured":"Flake, G. P. et al. The natural history of uterine leiomyomas: light and electron microscopic studies of fibroid phases, interstitial ischemia, inanosis, and reclamation. Obstet. Gynecol. Int. 2013, 528376 (2013).","journal-title":"Obstet. Gynecol. Int."},{"key":"493_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ajog.2020.02.016","volume":"223","author":"DD Baird","year":"2020","unstructured":"Baird, D. D. et al. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans. Am. J. Obstet. Gynecol. 223, 402 (2020).","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41574-021-00493-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-021-00493-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-021-00493-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:49:40Z","timestamp":1684619380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00493-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1038\/s41574-021-00493-2","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"type":"print","value":"1759-5029"},{"type":"electronic","value":"1759-5037"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"14 April 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}